<DOC>
	<DOCNO>NCT02846740</DOCNO>
	<brief_summary>This pilot study aim investigate whether treatment call cranial electric stimulation CES decrease risk factor suicide . The specific CES device use call Alpha-Stim® . CES use addition usual treatment ( medication group therapy ) .</brief_summary>
	<brief_title>Cranial Electric Stimulation Modify Suicide Risk Factors Psychiatric Inpatients .</brief_title>
	<detailed_description>Suicide still major issue United States around world . There many reason people attempt suicide major modifiable risk factor depression , anxiety , insomnia , agitation . The standard treatment suicidal patient include medication , admission hospital reduce risk factor . Medications potential side effect concern drug interaction . One biological treatment alternative medication cranial electric stimulation . This technique use device stimulate brain electrical current . Using Alpha-Stim® device , current apply brain use skin electrode easily clip earlobe . The amount current use low 1/1000 th current use electroconvulsive therapy ( ECT ) 1/10 th 1/20 th 1-2 milliampere use transcranial direct current stimulation ( tDCS ) . Our goal examine safety efficacy device use add-on adjunctive treatment usual treatment inpatient stay .</detailed_description>
	<mesh_term>Suicide</mesh_term>
	<criteria>1 . Subject must patient admit voluntarily UMMC adult psychiatric inpatient service suicidal thought / intent / plan suicide attempt also MSRFs include anxiety , agitation , insomnia , and/or depression ) . 2 . Subject must age 18 65 ( inclusive ) . Both men woman include 3 . Subjects female must negative pregnancy test prior enrol study , must practice least one follow method contraception study : intrauterine device ( IUD ) , barrier method combination spermicide , oral/hormonal contraception abstinence , typically case inpatient unit . 4 . If subject substance abuse disorder , must also another nonsubstance abuse psychiatric disorder determine clinical history . 5 . Chronic medical condition endocrine disease , hypertension , renal disease , must stable . 6 . Subject must capable give informed consent . Subject must provide write informed consent prior study participation . 7 . Subject must capable active sham CES treatment complete study requirement . 1 . Subject significant medical disorder acute symptom could impair reliable participation trial affect MSRFs . 2 . Subject pregnant . 3 . Subject concomitant therapy another investigational drug , participation investigational drug study within one month prior enter study . 4 . Subject clinical history poor compliance investigator 's judgment participation study would clinically contraindicate . 5 . Subject current past behavior suggest investigator his/her suicidal behavior drive secondary gain , i.e . express suicidal thought s/he admit due homelessness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>cranial electric stimulation</keyword>
	<keyword>suicide</keyword>
	<keyword>psychiatric inpatient</keyword>
</DOC>